Treatment gaps in renal cell cancer can compromise care. Knowing where they are is the first step toward addressing them; the next is to widen the use of evidence-based medicine.
Neither low-dose aspirin nor low-dose clonidine protects high-risk heart patients from cardiac complications after noncardiac surgery, and aspirin increases bleeding risk.
Cleveland Clinic will collaborate on the development of injectable artificial platelets under a $1.9 million NIH grant. Researchers will refine and test platelet designs in biologic models.
PSCK9 inhibitors are demonstrating safe, significant LDL-lowering ability in patients for whom therapy with statins or ezetimibe is not sufficient or not tolerated.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
An increasing share of oropharyngeal cancers are due to HPV infection, which is translating to better treatment response. And emerging findings suggest a bacterial connection with oral cancers.
Cleveland Clinic surgeons are using 3-D-printed polymer models to help craft novel endovascular grafts, replacement valves, artificial hearts and more.
Head-to-head study analyzing both costs and outcomes in outpatient vs. inpatient regimens finds no difference clinically but lower cost for outpatient therapy.
Last year, Cleveland Clinic’s Department of Radiation Oncology enrolled over 100 patients in Radiation Therapy Oncology Group clinical trials, topping recruitment numbers of all members of the research cooperative.
New guidelines simplify heart valve disease management by recommending best approaches for each stage of severity.
The Khorana score, named for its developer, Cleveland Clinic hematologist/oncologist Alok Khorana, MD, effectively forecasts cancer patients’ blood clotting risk based on a collection of simple variables — type of cancer, body mass index and complete blood count.